Oxytocin Injection, Solution
NDC Package 70518-4233-0
Package Information
Oxytocin injection is IMPORTANT NOTICE: Oxytocin Injection, USP (synthetic) is indicated for the medical rather than the elective induction of labor. Available data and information are inadequate to define the benefits to risks considerations in the use of the drug product for elective induction. Elective induction of labor is defined as the initiation of labor for convenience in an individual with a term pregnancy who is free of medical indications. This formulation utilizes a injection, solution delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4233 and is authorized under FDA application NDA018248.
Identification & Billing
- RxCUI: 1791721 - oxytocin 10 UNT in 1 ML Injection
- RxCUI: 1791721 - 1 ML oxytocin 10 UNT/ML Injection
- RxCUI: 1791721 - oxytocin 10 UNT per 1 ML Injection
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 70518 - Remedyrepack Inc.
- 70518-4233 - Oxytocin
- 70518-4233-0 - 25 VIAL in 1 TRAY / 1 mL in 1 VIAL (70518-4233-1)
- 70518-4233 - Oxytocin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70518-4233-0 identifies a specific commercial package of 25 vial in 1 tray / 1 ml in 1 vial (70518-4233-1) of Oxytocin, a human prescription drug labeled by Remedyrepack Inc.. This injection, solution is formulated for intramuscular; intravenous use and contains oxytocin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on November 18, 2024. The current certification is valid through December 31, 2026.
How is this Remedyrepack Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518423300. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.